Nine major pharmaceutical companies have agreed to pool data on drug trials with academic institutions in an effort to improve ways of developing of new prescription medicines to treat psychiatric disorders such as schizophrenia. The collaboration, which involves Pfizer, AstraZeneca, Eli Lilly and Roche among others, will bring together data on 67 trials on 11 [...]
Continue reading...Wednesday, March 31, 2010
Pfizer Inc on Wednesday said it paid $35 million to some 4,500 doctors and researchers from July through December 2009 for a variety of services, including speaking fees, expert advice and work on clinical trials of its medicines. The world’s largest drugmaker last year agreed to pay a record $2.3 billion fine and plead guilty [...]
Continue reading...Monday, February 8, 2010
Generic-drug makers Teva and Actavis, backed by Swedish buyout firm EQT, have placed make-or-break bids for German peer Ratiopharm but drug major Pfizer is expected to also be a contender, sources said. Ratiopharm could stay in takeover talks with two or even three bidders, as some bids, which had been due by the end of [...]
Continue reading...
Thursday, November 11, 2010
0 Comments